ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
732Followers
0Topic
0Badge
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 252 shares, the number of shares held increased 1.04% compared to the previous period and now represents 0.97% of the total position.
ARKG Investment Tracker position change: Increased position in Veracyte by 13,455 shares, the number of shares held increased 1.04% compared to the previous period and now represents 5.11% of the total position.
ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 21,690 shares, the number of shares held increased 1.04% compared to the previous period and now represents 9.2% of the total position.
ARKG Investment Tracker position change: Increased position in Veeva by 657 shares, the number of shares held increased 1.04% compared to the previous period and now represents 1.39% of the total position.
ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 26,478 shares, the number of shares held increased 1.04% compared to the previous period and now represents 3.5% of the total position.
ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 126 shares, the number of shares held increased 1% compared to the previous period and now represents 0.9% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 121,248 shares, the number of shares held increased 1.04% compared to the previous period and now represents 2.28% of the total position.
ARKG Investment Tracker position change: Increased position in Natera by 3,303 shares, the number of shares held increased 1.04% compared to the previous period and now represents 5.08% of the total position.
ARKG Investment Tracker position change: Increased position in Illumina by 990 shares, the number of shares held increased 1.04% compared to the previous period and now represents 1.28% of the total position.
ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 28,476 shares, the number of shares held increased 1.04% compared to the previous period and now represents 3.34% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 33,532 shares, the number of shares held decreased 3.27% compared to the previous period and now represents 3.52% of the total position.
ARKG Investment Tracker position change: Increased position in Incyte by 1,602 shares, the number of shares held increased 1.04% compared to the previous period and now represents 1.04% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 115,614 shares, the number of shares held increased 1.04% compared to the previous period and now represents 6.85% of the total position.
ARKG Investment Tracker position change: Increased position in Amgen by 657 shares, the number of shares held increased 1.03% compared to the previous period and now represents 1.67% of the total position.
ARKG Investment Tracker position change: Increased position in Exact Sciences by 783 shares, the number of shares held increased 1.03% compared to the previous period and now represents 0.43% of the total position.
ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 21,897 shares, the number of shares held increased 1.04% compared to the previous period and now represents 4.11% of the total position.
ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 14,274 shares, the number of shares held increased 1.04% compared to the previous period and now represents 4.32% of the total position.
ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 17,568 shares, the number of shares held increased 1.04% compared to the previous period and now represents 4.59% of the total position.
ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 17,829 shares, the number of shares held increased 1.04% compared to the previous period and now represents 7% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 1,484 shares, the number of shares held decreased 5.77% compared to the previous period and now represents 1.09% of the total position.
Go to Tiger App to see more news